ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 74 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $2,580,000 | -17.6% | 525,628 | -11.4% | 0.01% | -16.7% |
Q2 2021 | $3,132,000 | +112.1% | 593,265 | +92.8% | 0.01% | +100.0% |
Q1 2021 | $1,477,000 | +37.9% | 307,700 | +24.4% | 0.01% | +50.0% |
Q4 2020 | $1,071,000 | +15.8% | 247,278 | +10.1% | 0.00% | 0.0% |
Q3 2020 | $925,000 | +195.5% | 224,542 | +83.7% | 0.00% | +300.0% |
Q2 2020 | $313,000 | +490.6% | 122,259 | +572.4% | 0.00% | – |
Q1 2020 | $53,000 | -93.8% | 18,183 | -39.5% | 0.00% | -100.0% |
Q4 2015 | $850,000 | -51.7% | 30,034 | -71.4% | 0.00% | -60.0% |
Q3 2015 | $1,759,000 | -78.9% | 105,039 | -67.0% | 0.01% | -75.6% |
Q2 2015 | $8,352,000 | +25.5% | 318,613 | -16.2% | 0.04% | +32.3% |
Q1 2015 | $6,655,000 | +103.5% | 380,320 | +102.0% | 0.03% | +106.7% |
Q4 2014 | $3,270,000 | +2340.3% | 188,313 | +2523.8% | 0.02% | +1400.0% |
Q3 2014 | $134,000 | – | 7,177 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |